Supernus Pharmaceuticals IncAdd to My Watchlist

SUPN:USNASDAQ GMIndustry: Medical-Drugs
  • 9.27
  • 0.28  3.11%
    Today's Change
  • 8.99
    Previous Close
  • Today
    52 Week Low - High
11:18 am ET 3/2/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding43 million
Market Cap$398 million
Return on Equity ttm-17.54%
Last DividendSUPN:US does not pay a dividend
EPS: Year Actual ttm-0.030
EPS: Year Est. 12/14 ttm0.303
EPS: Quarterly Actual 9/14 -0.04
EPS: Quarterly Est. 12/14 -0.01
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-6.62
Company Description
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.
Revenue$12 million
Net Income$-92 million
Total Assets$111 million

Latest Headlines


Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now


Not Registered?

Get complete access to The Washington Post online - it's FREE!